Plakortin (1) is a remarkably simple 1,2-dioxane derivative, extracted from the marine sponge Plakortis simplex, showing a submicromolar activity against chloroquine-resistant strains of Plasmodium falciparum. Using plakortin as a novel antimalarial hit, we have prepared a series of semisynthetic derivatives in order to gain insights into the structural requirements of simple 1,2-dioxanes for exhibiting antimalarial activity. Their synthesis, spectroscopic and computational analysis, and in vitro antimalarial activity are herein reported. Results obtained, besides confirming the crucial role of the cycloperoxide functionality, revealed other structural features critical for antimalarial activity, namely the "Western" alkyl side chain, the dioxane ring conformation, and the absolute configuration of the stereogenic carbons on the 1,2-dioxane ring, when affecting the bioactive ring conformation.
Introduction
Malaria, a parasitic disease caused by protozoans belonging to the genus Plasmodium, is recognized as one of the most dramatic public health concerns of our days. Indeed, it occurs in over 90 countries worldwide and, according to valuations provided by the World Health Organization, 300 to 500 million clinical cases of malaria occur and 1.5-2 million people (most of them young children living in sub-Saharan Africa) are killed each year. 1 The difficulties associated with the preparation of an effective vaccine against malaria can be ascribed to the complexity of this disease, that varies widely in epidemiology (variability in the species of malaria parasite that occur in a given area) and clinical manifestations in different parts of the world. However, the development and spread of drug-resistant strains of malaria parasites is probably the key factor in the resurgence of malaria emergency, also in areas where the disease had been eradicated, and is one of the greatest challenges to malaria control today. 2 Unfortunately, the rate at which resistance is growing outpaces the development of new antimalarials and, thus, the number of effective drugs available to treat resistant malaria remains small.
Artemisinin, a cycloperoxide-containing sesquiterpene lactone extracted from the plant Artemisia annua, shows higher activity against chloroquine-resistant strains (CQ-R) than chloroquinesensitive strains (CQ-S) of P. falciparum. Accordingly, a series of artemisinin semisynthetic derivatives (artesunate, artemether, arteether), with improved pharmacokinetic properties, have been proposed for the treatment of severe malaria and, in some areas of South-East Asia, their combination with mefloquine offer the only reliable treatment for multidrug-resistant malaria. 3 However, also in the case of artemisinin-derived molecules some problems are appearing. These are mostly related to (i) some adverse effects (neurological and embriological) caused by their use, 4 (ii) the costs associated with the extraction of artemisinin from natural sources and the complexity of alternative chemical syntheses. 5 For these reasons, there is an urgent need for the rapid development of effective, safe, and synthetically affordable antimalarial agents. In this regard, we have been focusing our interest on 1,2-dioxane derivatives isolated from the Caribbean sponge Plakortis simplex possessing remarkably simple skeletons: the parent compounds of this class, plakortin (1) and its 9,10-dihydro analogue 2, have been demonstrated to possess in vitro antimalarial activity in the submicromolar range, being particularly active on CQ-R strains (IC 50 ) 0.41 µM), and devoid of general cytotoxicity. 6, 7 More recently, we have isolated two additional analogues of plakortin from the same sponge, namely 3-epiplakortin (3) and plakortide Q (4) (Figure 1 ). 8 These analogues showed in vitro antimalarial activity similar to that of plakortin (IC 50 ) 0.51 µM), suggesting that the activity of this class of compounds is not strictly dependent on a definite configuration of the stereogenic carbons belonging to the 1,2-dioxane ring. Due to the tremendous need to develop new classes of affordable, rapidly acting drugs to treat uncomplicated malaria, exploiting the natural compound plakortin (1) as a novel antimalarial hit, we herein report the synthesis, the spectroscopic and computational analysis, and the in vitro antimalarial activity of a series of plakortin semisynthetic derivatives.
Chemistry. Plakortin (1) can be isolated in high amounts (more than 5% of the organic extract) from Plakortis simplex, following a very simple procedure, and it is stable under extraction and chromatographic purification steps. 6 The availability of reasonable amounts of 1, its stability, and the presence in its monocyclic skeleton of functional groups that could be modified, appeared a good opportunity to investigate the effect of chemical transformations on antimalarial activity, allowing an extension of the structure-activity relationships (SARs) for this class of antimalarial endoperoxides.
The simple structure of plakortin offers three points for chemical interconversion: (i) the cycloperoxide bond, (ii) the carbon-carbon double bond, (iii) the ester group. These functionalities have been subjected to simple chemical reactions and the products obtained (5-12) have been fully characterized by means of MS and 1D and 2D NMR spectroscopy (data are listed in the Experimental Section).
A selective reduction of the cycloperoxide bond was accomplished upon treatment of plakortin (1) with acetic acid and Zn dust in dry ether, affording the diol 5 in good yield (Scheme 1). As for the ester group, its selective reduction, without affecting the cycloperoxide bond, was carried out by treating 1 with LiBH 4 in dry THF, thus obtaining the primary alcohol derivative 6. The methylation of this group (compound 7) was performed upon treatment with methyl triflate in the presence of an excess of 2,6-di-tert-butylpyridine, while its acetylation, performed under standard conditions (acetic anhydride, pyridine), yielded compound 8 in quantitative amounts (Scheme 1).
Finally, we turned out our attention to reactions of the carbon-carbon double bond (Scheme 2). Its oxidative cleavage (KMnO 4 /NaIO 4 in t-BuOH/Na 2 CO 3 ) afforded the carboxylic acid derivative 9 in high yield (80%). A portion of compound 9 was subsequently methylated with diazomethane, obtaining a quantitative conversion into compound 10. The double bond of plakortin (1) was also epoxidized with meta-chloro-perbenzoic acid in dry CH 2 Cl 2 and, as expected, this reaction afforded two different epoxides, 11 and 12, deriving from the syn approach of the reagent from both sides of the trans double bond. The trans geometry of the epoxide ring was unambiguously demonstrated for both 11 and 12 through the 2D ROESY spectrum: cross-peaks corresponding to the spatial coupling of H-9 with H 2 -11 were detected in both cases (11: δ 2.44 with δ 1.58; 12: δ 2.52 with δ 1.55). Given the unsuitability of X-ray structure determination, due to the oily nature of the compounds, determination of the correct absolute configuration at the epoxide carbons of 11 and 12 required a different strategy. In particular, a reaction that opened the epoxide ring and left (preferably) one secondary alcohol group, to be subjected to the Mosher methodology, appeared appropriate. To this end, we first attempted an application of the recently reported mild epoxide ring opening by reaction with methanol, catalyzed by copper(II) tetrafluoroborate, 9 but, unfortunately, a complex mixture of products, apparently coming from concomitant reactions of the cycloperoxide bond, was obtained. Thus, we decided to turn to the complete reduction of one of the two epoxides (12), by using LiAlH 4 in dry ether. In this way, only two tetraol derivatives, 13 and 14, were obtained, and inspection of their NMR spectra confirmed that they actually were two regioisomers differing for the position of only one hydroxyl group (at C-10 and at C-9, respectively). Compound 13 was then esterified by using an excess of (R)-and (S)-MTPA chloride in dry pyridine, thus obtaining the MTPA triester derivatives 15 and 16, respectively. These were analyzed following the modified Mosher method, 10 and the S configuration was thus assigned at C-10 of 13. Consequently, the S configuration could be assigned at C-10 of 12 and, given the trans geometry of the epoxide ring in 12, its absolute configuration was determined as 9S,10S. On account of the enantiomeric relationship existing between the epoxide carbons of 11 and 12, we assigned the absolute configuration of the corresponding chiral carbons in 11 as 9R,10R.
Results and Discussion
The new semisynthetic plakortin derivatives 5-12 were tested for their in vitro antimalarial activity, using the pLDH assay, against D10 (chloroquine sensitive, CQ-S) and W2 (chloroquine resistant, CQ-R) strains of P. falciparum. Results are reported in Table 1 .
First, it is noteworthy the complete inefficacy of diol 5, demonstrating that, as reported for artemisinins, the cycloperoxide functionality plays a crucial role in the antimalarial activity of plakortin derivatives. Second, all the new semi- synthetic compounds are more active on W2 (CQ-R strains) than on D10 (CQ-S strains), with the exception of 9 which presents similar activity on both strains. Going into detail, some interesting considerations can be made: (i) the substitution of the ester function (1) with different groups such as hydroxy (6) , methoxy (7), and acetoxy (8) does not affect activity and selectivity for the tested strains of Plasmodium falciparum; moreover, these compounds present a collinearity between the activity variation on D10 (CQ-S strains) and W2 (CQ-R strains); (ii) changes on the "Western" alkyl side chain appear to have a more significant effect on the antimalarial activity, differently affecting activity against CQ-S and CQ-R strains. The decreased activity of compound 9 against both P. falciparum strains suggests unfavorable parasite penetration properties due to the presence of the free carboxylic function. Accordingly, the esterification of the carboxylic group (10) determines a slight overall improvement in the antimalarial activity. On the other hand, compounds 11 and 12 show an activity similar to that of 9 on CQ-S strains, while they exhibit a 2-fold increase of activity against CQ-R strains. Interestingly, some data available in the literature for plakortin-related molecules appear to strengthen the observation that changes on the "Western" alkyl side chain can significantly influence the antimalarial activity. Compounds 17 and 18 (Figure 2 ), which are close analogues of plakortin (1) , are much less active than 1. 11 In particular, compound 17 shows a reduced activity (IC 50 1.9 µM) on W2 (CQ-R strain), while compound 18, differing only for the absence of the ketone group, is practically inactive (IC 50 > 10 µM) on W2. 11 In order to investigate the role played by the conformational parameters on the antimalarial activity of plakortin-related endoperoxides, we performed a full computational analysis on the new derivatives 6-12 as well as on the reference compounds 1-4 6-8 and on the plakortin-related compounds 17 and 18. 11 The resulting conformers can been grouped into four families ( Figure 3 ) in relation to the dioxane ring conformations, named chair A, chair B, boat A, and boat B (Table 2) , demonstrating a strong preference for the chair conformations, in agreement with the previously observed conformational behavior of the 1,2 dioxane ring system. 12 It can be noted that all the molecules exhibiting a good antimalarial activity (i.e., IC 50 < 1 µM on CQ-R strains, 1-4, 6-12) present the same conformational preference of the dioxane ring (Chair A, Table 2 ). It is noteworthy that, while the epimerization at C-3 (3 and 4) does not affect the conformation of the dioxane ring, the change in the conformational behavior (Table 2 ) of compounds 17 and 18 can be attributed to the concomitant epimerization at C-4, which changes the relative orientation of the ethyl chain with respect to the "Western" alkyl side chain ( Figure S1 , Supporting Information). The importance of the endoperoxide ring conformation is strengthened by comparison with the structure of artemisinin. Indeed, the most favorite conformation (Chair A) of the dioxane ring of plakortin (1) and its active derivatives overlaps well with the peroxide ring-constrained conformation of artemisinin (Figure 4 ). On the other hand, the complete lack of activity of compound 18 with respect to 17 confirms that small changes in the "Western" alkyl side chain of plakortinrelated structures can markedly influence the antimalarial activity, even if the molecules show the same conformation of the dioxane ring.
Conclusions
The mechanism of action of plakortin as well as that of related simple endoperoxides is still a matter of debate. However, the present study, besides confirming the crucial role of the cycloperoxide functionality, took into consideration other structural features critical for antimalarial activity: (i) the "Western" alkyl side chain, (ii) the dioxane ring conformation, (iii) the absolute configuration of the sterogenic carbons on the 1,2-dioxane ring, only when affecting the bioactive dioxane ring conformation. This latter observation, together with the com- parable activity of the diastereomers 11 and 12, suggests the absence of a stereospecific interaction with the putative antimalarial molecular target. A thorough investigation on the mechanism of action of plakortins, which is ongoing in our laboratories, could better clarify the role of the "Western" side chain and of the dioxane ring conformation in modulating the activity of these simplified cycloperoxide scaffolds, providing further valuable information to optimize the antimalarial profile of novel, synthetically affordable, endoperoxides of the plakortin series.
Experimental Section
General Methods. Optical rotations (CHCl 3 ) have been measured on a Perkin-Elmer 192 polarimeter equipped with a sodium lamp (λ ) 589 nm) and a 10-cm microcell. Low-resolution ESIMS (positive ions) experiments were performed on an Applied Biosystem API 2000 triple quadrupole mass spectrometer. The spectra were recorded by infusion into the ESI source using MeOH as the solvent. Low-and high-resolution EI mass spectra (70 eV, direct inlet) were performed on a VG Prospec (FISONS) mass spectrometer. 1 H (500 MHz) and 13 C (125 MHz) NMR spectra were determined on a Varian UnityInova 500 NMR spectrometer; chemical shifts are referenced to the residual solvent signal (CDCl 3 : δ H ) 7.26, δ C ) 77.0). Homonuclear 1 H connectivities were determined by COSY experiments. Through-space 1 H connectivities were demonstrated using a 2D ROESY experiments with a mixing time of 500 ms. One bond heteronuclear 1 H-13 C connectivities were determined with the HSQC experiment. Two and three bond 1 H-13 C connectivities were determined by HMBC experiments optimized for a 3 J CH of 8.0 Hz. Medium-pressure liquid chromatography (MPLC) was performed using a Büchi 861 apparatus using Merck SI60 (230-400 mesh) stationary phase. High performance liquid chromatography (HPLC) separations in isocratic mode were achieved on a Beckmann apparatus equipped with refractive index detector and with Phenomenex LUNA SI60 (250 × 4 mm) columns.
Animal Material, Extraction, and Isolation. A specimen of Plakortis simplex was collected in July 2002 along the coasts of Bahamas. A voucher specimen is deposited at the Dipartimento di Chimica delle Sostanze Naturali, Italy with the ref n . 02-10. The organism was immediately frozen after collection and kept frozen until extraction, when the sponge (43 g, dry weight after extraction) was homogenized and extracted with methanol (4 × 500 mL) and with chloroform (4 × 500 mL). The methanol extract was initially partitioned between H 2 O and n-BuOH, and then the organic phase was combined with the CHCl 3 extract and concentrated in vacuo to afford a brown oil (22.1 g). This was subjected to chromatography on a column packed with RP18 silica gel and eluted with 13 C-14) . Reduction of the Ester Group of Plakortin. Plakortin (1, 100 mg, 0.32 mmol) was dissolved in 3.0 mL of dry THF under argon flow at 0°C, and then 450 µL of a 2 M solution of LiBH 4 in THF (0.9 mmol) and 30 µL of dry MeOH were added dropwise to the solution. The reaction was kept under stirring for 2 h at 0°C. Then, 30 µL of 1 M aqueous NaOH was added to the obtained mixture, which was partitioned between water and CHCl 3 . The organic phase, dried with Na 2 SO 4 and concentrated in vacuo, was purified by HPLC (LUNA SI60 250 × 4 eluent n-hexane/EtOAc 75:25) affording pure compound 6 (78 mg, 0.28 mmol, 87.5% yield). Acetylation of Compound 6. Compound 6 (20 mg, 0.070 mmol) was dissolved in dry pyridine (1 mL) and treated with Ac 2 O (1 mL). After standing overnight, the reaction was worked up by addition of a few drops methanol to destroy the excess Ac 2 O, water (ca. 5 mL), and EtOAc (ca. 15 mL). The organic phase was washed sequentially with 2 N H 2 SO 4 , saturated NaHCO 3 , and brine. After drying (Na 2 SO 4 ) and removal of the solvent, 22.0 mg (0.069 mmol) of compound 8 was obtained. (H 3 -12 , t, J ) 6.6 Hz); 0.88 (H 3 -14, t, J ) 6.6 Hz); 0.80 (H 3 -17, t, J ) 6.6 Hz). 13 14 (H-13b, m); 0.90 (H 3 -14, t, J ) 6.6 Hz); 0.88 (H 3 -11, t, J ) 6.6 Hz). 13 C NMR (CDCl 3 ): δ 176.8 (C-9); 172.2 (C-1); 80.1 (C-6); 78.7 (C-3); 51.9 (OCH 3 ); 51.6 (OCH 3 ); 41.9 (C-7); 41.6 (C-8); 34.7 (C-4); 34.3 (C-5); 31.3 (C-2); 27.5 (C-10); 25.0 (C-13); 21.0 (C-12); 11.5 (C-11); 11.0 (C-14).
Epoxidation of Plakortin. Plakortin (110 mg, 0.353 mmol) was dissolved in 4 mL of dry CH 2 Cl 2 , and 84 mg of meta-chloroperbenzoic acid (0.494 mmol) was added to the solution that was then stirred overnight at room temperature. Subsequently, the reaction mixture was partitioned between CHCl 3 and saturated aqueous NaHCO 3 . The organic phase, dried and concentrated in vacuo, was then purified by HPLC (LUNA, SI60, eluent n-hexane/EtOAc 9:1) yielding compounds 11 (41 mg, 0.125 mmol, 35% yield) and 12 (45 mg, 0.137 mmol, 39% yield) in the pure state. In order to properly analyze the electronic properties, their most stable conformers were subjected to a full geometry optimization by semiempirical calculations, using the quantum mechanical method AM1 in the Mopac 6.0 package 17 in Ampac/ Mopac module of Insight 2000.1. GNORM value was set to 0.5. To reach a full geometry optimization the criteria for terminating all optimizations was increased by a factor of 100, using the keyword PRECISE. The lowest energy conformer of Plakortin (1) was superimposed on artemisinin X-ray structure (CSDS code: QNGHSU) by fitting the 1,2-dioxane ring on the 1,2,4-trioxane ring.
